Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nextleaf Solutions Ltd C.OILS

Alternate Symbol(s):  OILFF

Nextleaf Solutions Ltd. is a cannabis processor with a portfolio of federally regulated emerging consumer brands, market validated cannabis derivative products, and high-potency bulk ingredients. The Company’s multi-patented, highly automated, closed loop extraction, and distillation technology sets the global standard for processing cannabis at scale. The Company manufactures over 80 different products, across four categories for white label clients and house brands. It manufactures and distributes cannabis vapes and oils under multiple brands including its brand, Glacial Gold, and the High Plains brand. The Company sells its branded cannabinoid vapes, oils, and soft gels to the British Columbia Liquor Distribution Branch (BCLDB), Ontario Cannabis Store (OCS), Nova Scotia Liquor Commission (NSLC), Manitoba Liquor & Lotteries (MBLL) National Cannabis Distribution in Saskatchewan, and across Canada through multiple medical platforms, select pharmacies, and a distribution agreement.


CSE:OILS - Post by User

Bullboard Posts
Post by Kensin1954on Nov 05, 2019 12:46pm
63 Views
Post# 30311082

Todays Market talking point.

Todays Market talking point."But CBD is used by GW Pharmaceuticals PLC GWPH, +2.51% in its Epidiolex, a treatment for certain forms of epilepsy, and the U.S. Food and Drug Administration categorizes it as a drug. The FDA has said companies are not allowed to add CBD to food or drinks or to make health claims, as the agency works to come up with a regulatory framework."

Quote" From Deep Dive article on CBD company buy out.

This is the talking point about CBD

The U.S. is lagging due to corrosive politics in Washington 

It does not take away the value of CBD to the Medical industry. This is just the beginning.

JMHO
Bullboard Posts